Page last updated: 2024-08-21

isoxazoles and Adrenocorticotropic Hormone, Inappropriate Secretion

isoxazoles has been researched along with Adrenocorticotropic Hormone, Inappropriate Secretion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boerger, C; Burkhart, JL; Emmerich, J; Hartmann, RW; Hu, Q; Laschke, MW; Menger, MD; Scheuer, C; Siebenbürger, L; van Koppen, CJ	1

Other Studies

1 other study(ies) available for isoxazoles and Adrenocorticotropic Hormone, Inappropriate Secretion

Article	Year
Lead Optimization Generates CYP11B1 Inhibitors of Pyridylmethyl Isoxazole Type with Improved Pharmacological Profile for the Treatment of Cushing's Disease. Journal of medicinal chemistry, 2017, 06-22, Volume: 60, Issue:12 Topics: Administration, Oral; Animals; Biological Availability; Chemistry Techniques, Synthetic; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Drug Stability; ERG1 Potassium Channel; Female; Humans; Inactivation, Metabolic; Inhibitory Concentration 50; Isoxazoles; Pituitary ACTH Hypersecretion; Pyridines; Rats, Sprague-Dawley; Steroid 11-beta-Hydroxylase; Toxicity Tests	2017

Article

Year

Lead Optimization Generates CYP11B1 Inhibitors of Pyridylmethyl Isoxazole Type with Improved Pharmacological Profile for the Treatment of Cushing's Disease.

Journal of medicinal chemistry, 2017, 06-22, Volume: 60, Issue:12

Topics: Administration, Oral; Animals; Biological Availability; Chemistry Techniques, Synthetic; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Drug Stability; ERG1 Potassium Channel; Female; Humans; Inactivation, Metabolic; Inhibitory Concentration 50; Isoxazoles; Pituitary ACTH Hypersecretion; Pyridines; Rats, Sprague-Dawley; Steroid 11-beta-Hydroxylase; Toxicity Tests

2017